Yesterday was excellent day for Renuka. She underwent for 3 month follow up whole body PET scan to understand treatment response. As soon as she got her report, she immediately shared her report and talked to me. The report says ".... previously noted mass lesion has shown complete interval metabolic and morphological resolution." We literally cried joyfully over the phone. We were so happy to note that the medicine is responding her very well. I am thankful to all my supporters for their donations and keeping my spirit alive for Renuka, Long way to go for the medicine supply. Renuka and her family are still fighting for availability of low-cost medicine. Thank you for your support and prayers.
I met Renuka in India. She is very positive for her cure. She has non-small cell lung (NSCL) cancer, EGFR gene positive. She is on targeted therapy. Osimertinib is the drug from AstraZeneca which inhibits EGFR's Tyrosine kinase (TK) activity. Low cost Osimertinib drug is available from Bangladesh, however, due to political crisis in Bangladesh, it is difficult to get the drug in India and many patients suffer for unavailability of low cost Osimertinib. This treatment is very costly. If anyone from AstraZeneca, USA supports Renuka's treatment would be highly appreciated. I will be happy to connect with Renuka and her family. For help connect me at patelbp2487@gmail.com. Thank you.